A Phase I Study of Imexon Plus Gemcitabine as First-Line Therapy for Advanced Pancreatic Cancer
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-009-1162-y
Full Text
Open PDFAbstract
Available in full text
Date
October 24, 2009
Authors
Publisher
Springer Science and Business Media LLC